Demant
Demant A/S, commonly known as Demant, is a leading global player in the hearing healthcare and personal communication industry, headquartered in Denmark (DK). Founded in 1904, the company has evolved significantly, marking key milestones such as the introduction of innovative hearing aids and advanced audiometric equipment. Demant operates extensively across Europe, North America, and Asia, focusing on hearing aids, audiometric instruments, and personal communication solutions. Their core products, renowned for their cutting-edge technology and user-centric design, set them apart in a competitive market. With a strong commitment to research and development, Demant has established itself as a trusted name, achieving notable recognition for its contributions to improving the quality of life for individuals with hearing loss.
DitchCarbon Score
How does Demant's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Demant's score of 57 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Demant's reported carbon emissions
In 2024, Demant A/S reported total greenhouse gas emissions of approximately 493,529,000 kg CO2e, with emissions distributed across various scopes: 14,645,000 kg CO2e (Scope 1), 14,781,000 kg CO2e (Scope 2), and 464,103,000 kg CO2e (Scope 3). This data reflects a comprehensive approach to emissions reporting, including significant contributions from purchased goods and services, which accounted for the majority of their Scope 3 emissions. Demant has set ambitious climate commitments, aiming for a minimum 50% reduction in absolute Scope 1 and 2 emissions by 2030, using 2019 as the baseline year. Additionally, they target a 46.2% reduction in absolute Scope 3 emissions within the same timeframe. Long-term goals include a 90% reduction in both Scope 1 and 2 emissions and Scope 3 emissions by 2050, also from a 2019 baseline. These targets align with the Science Based Targets initiative (SBTi) and demonstrate Demant's commitment to achieving net-zero greenhouse gas emissions across its value chain by 2050. The company is actively working towards these goals, reflecting a strong commitment to sustainability and climate action within the healthcare technology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 4,368,000 | - | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 19,897,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Demant is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
